financetom
Business
financetom
/
Business
/
EU drug regulator allows Novo Nordisk to include heart condition in Ozempic label
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU drug regulator allows Novo Nordisk to include heart condition in Ozempic label
Jun 23, 2025 12:14 PM

June 23 (Reuters) - Novo Nordisk said on

Monday the European drugs regulator has adopted a positive

opinion for an update of the Ozempic label to include peripheral

artery disease.

(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shinjini

Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved